{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:03:24Z","timestamp":1791407004127,"version":"4.3.3"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/s12958-025-01506-9","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:55:21Z","timestamp":1764842121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Women with endometriosis who undergo IVF: a contemporary review of therapeutic strategies for successful outcomes"],"prefix":"10.1186","volume":"24","author":[{"given":"Alexander M.","family":"Kotlyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"10276","key":"1506_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","volume":"397","author":"HS Taylor","year":"2021","unstructured":"Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839\u201352.","journal-title":"Lancet"},{"key":"1506_CR2","doi-asserted-by":"crossref","unstructured":"Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril, 1997;67(5);817\u201321.","DOI":"10.1016\/S0015-0282(97)81391-X"},{"issue":"3","key":"1506_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.fertnstert.2012.05.031","volume":"98","author":"Endometriosis and infertility","year":"2012","unstructured":"Endometriosis and infertility. A committee opinion. Fertil Steril. 2012;98(3):591\u20138.","journal-title":"Fertil Steril"},{"key":"1506_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0002-9378(15)30003-X","volume":"14","author":"JA Sampson","year":"1927","unstructured":"Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;14:422\u201369.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1506_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0002-9378(86)90389-3","volume":"154","author":"JS Sanfilippo","year":"1986","unstructured":"Sanfilippo JS, et al. Endometriosis in association with uterine anomaly. Am J Obstet Gynecol. 1986;154(1):39\u201343.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1506_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/stem.2804","volume":"36","author":"F Li","year":"2018","unstructured":"Li F, et al. Hematogenous dissemination of mesenchymal stem cells from endometriosis. Stem Cells. 2018;36(6):881\u201390.","journal-title":"Stem Cells"},{"issue":"Suppl 1","key":"1506_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000052855","volume":"47","author":"K Matsuura","year":"1999","unstructured":"Matsuura K, et al. Coelomic metaplasia theory of endometriosis: evidence from in vivo studies and an in vitro experimental model. Gynecol Obstet Invest. 1999;47(Suppl 1):18\u201320 (discussion 20-2).","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"1506_CR8","doi-asserted-by":"publisher","first-page":"e0268299","DOI":"10.1371\/journal.pone.0268299","volume":"17","author":"T Ochi","year":"2022","unstructured":"Ochi T, et al. Dynamics of thoracic endometriosis in the pleural cavity. PLoS ONE. 2022;17(5):e0268299.","journal-title":"PLoS ONE"},{"key":"1506_CR9","doi-asserted-by":"publisher","first-page":"2083121","DOI":"10.1155\/2018\/2083121","volume":"2018","author":"C Rei","year":"2018","unstructured":"Rei C, Williams T, Feloney M. Endometriosis in a man as a rare source of abdominal pain: a case report and review of the literature. Case Rep Obstet Gynecol. 2018;2018:2083121.","journal-title":"Case Rep Obstet Gynecol"},{"issue":"2","key":"1506_CR10","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/0002-9378(92)91706-G","volume":"166","author":"RL Barbieri","year":"1992","unstructured":"Barbieri RL. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol. 1992;166(2):740\u20135.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1506_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0015-0282(16)55911-1","volume":"59","author":"EG Hughes","year":"1993","unstructured":"Hughes EG, Fedorkow DM, Collins JA. A quantitative overview of controlled trials in endometriosis-associated infertility. Fertil Steril. 1993;59(5):963\u201370.","journal-title":"Fertil Steril"},{"issue":"1","key":"1506_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0015-0282(16)57650-X","volume":"64","author":"JA Collins","year":"1995","unstructured":"Collins JA, Burrows EA, Wilan AR. The prognosis for live birth among untreated infertile couples. Fertil Steril. 1995;64(1):22\u20138.","journal-title":"Fertil Steril"},{"issue":"1","key":"1506_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12958-023-01157-8","volume":"21","author":"E Somigliana","year":"2023","unstructured":"Somigliana E, et al. Endometriosis and IVF treatment outcomes: unpacking the process. Reprod Biol Endocrinol. 2023;21(1):107.","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"1506_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1056\/NEJMra0804690","volume":"360","author":"SE Bulun","year":"2009","unstructured":"Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268\u201379.","journal-title":"N Engl J Med"},{"issue":"8","key":"1506_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/aje\/kwh275","volume":"160","author":"SA Missmer","year":"2004","unstructured":"Missmer SA. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol. 2004;160(8):784\u201396.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"1506_CR16","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1093\/humrep\/det123","volume":"28","author":"G Uncu","year":"2013","unstructured":"Uncu G, et al. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod. 2013;28(8):2140\u20135.","journal-title":"Hum Reprod"},{"key":"1506_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13048-014-0108-0","volume":"7","author":"Y Chen","year":"2014","unstructured":"Chen Y, et al. The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-Mullerian hormone: a prospective cohort study. J Ovarian Res. 2014;7:108.","journal-title":"J Ovarian Res"},{"issue":"5","key":"1506_CR18","doi-asserted-by":"publisher","first-page":"589.e1","DOI":"10.1016\/j.ajog.2016.05.029","volume":"215","author":"LR Goodman","year":"2016","unstructured":"Goodman LR, et al. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol. 2016;215(5):589.e1-589.e6.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1506_CR19","first-page":"7","volume":"46","author":"DL Hock","year":"2001","unstructured":"Hock DL, et al. Contribution of diminished ovarian reserve to hypofertility associated with endometriosis. J Reprod Med. 2001;46(1):7\u201310.","journal-title":"J Reprod Med"},{"issue":"1","key":"1506_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0015-0282(16)47552-7","volume":"41","author":"RS Schenken","year":"1984","unstructured":"Schenken RS, et al. Etiology of infertility in monkeys with endometriosis: luteinized unruptured follicles, luteal phase defects, pelvic adhesions, and spontaneous abortions. Fertil Steril. 1984;41(1):122\u201330.","journal-title":"Fertil Steril"},{"issue":"8","key":"1506_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10815-010-9436-1","volume":"27","author":"C Bulletti","year":"2010","unstructured":"Bulletti C, et al. Endometriosis and infertility. J Assist Reprod Genet. 2010;27(8):441\u20137.","journal-title":"J Assist Reprod Genet"},{"issue":"11","key":"1506_CR22","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/1471-0528.12366","volume":"120","author":"HM Harb","year":"2013","unstructured":"Harb HM, et al. The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis. BJOG. 2013;120(11):1308\u201320.","journal-title":"BJOG"},{"issue":"1","key":"1506_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/AOG.0000000000000592","volume":"125","author":"M Hamdan","year":"2015","unstructured":"Hamdan M, et al. Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(1):79\u201388.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"1506_CR24","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/S0015-0282(02)03112-6","volume":"77","author":"K Barnhart","year":"2002","unstructured":"Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril. 2002;77(6):1148\u201355.","journal-title":"Fertil Steril"},{"issue":"5","key":"1506_CR25","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.fertnstert.2024.01.023","volume":"121","author":"S Alson","year":"2024","unstructured":"Alson S, et al. Endometriosis diagnosed by ultrasound is associated with lower live birth rates in women undergoing their first in vitro fertilization\/intracytoplasmic sperm injection treatment. Fertil Steril. 2024;121(5):832\u201341.","journal-title":"Fertil Steril"},{"issue":"1","key":"1506_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.fertnstert.2014.03.053","volume":"102","author":"PT Goud","year":"2014","unstructured":"Goud PT, et al. Dynamics of nitric oxide, altered follicular microenvironment, and oocyte quality in women with endometriosis. Fertil Steril. 2014;102(1):151-159.e5.","journal-title":"Fertil Steril"},{"issue":"3","key":"1506_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/09513590.2017.1391203","volume":"34","author":"I Kasapoglu","year":"2018","unstructured":"Kasapoglu I, et al. Detrimental effects of endometriosis on oocyte morphology in intracytoplasmic sperm injection cycles: a retrospective cohort study. Gynecol Endocrinol. 2018;34(3):206\u201311.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"1506_CR28","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s43032-020-00410-4","volume":"28","author":"Y Yin","year":"2021","unstructured":"Yin Y, et al. Insufficient cumulus expansion and poor oocyte retrieval in endometriosis-related infertile women. Reprod Sci. 2021;28(5):1412\u201320.","journal-title":"Reprod Sci"},{"issue":"4","key":"1506_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/oxfordjournals.humrep.a138578","volume":"9","author":"C Sim\u00f3n","year":"1994","unstructured":"Sim\u00f3n C, et al. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod. 1994;9(4):725\u20139.","journal-title":"Hum Reprod"},{"issue":"5","key":"1506_CR30","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.fertnstert.2007.05.038","volume":"89","author":"L Benaglia","year":"2008","unstructured":"Benaglia L, et al. Endometrioma and oocyte retrieval-induced pelvic abscess: a clinical concern or an exceptional complication? Fertil Steril. 2008;89(5):1263\u20136.","journal-title":"Fertil Steril"},{"issue":"6","key":"1506_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/BF02765839","volume":"14","author":"JS Younis","year":"1997","unstructured":"Younis JS, et al. Late manifestation of pelvic abscess following oocyte retrieval, for in vitro fertilization, in patients with severe endometriosis and ovarian endometriomata. J Assist Reprod Genet. 1997;14(6):343\u20136.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"1506_CR32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/humupd\/dmv035","volume":"21","author":"M Hamdan","year":"2015","unstructured":"Hamdan M, et al. The impact of endometrioma on IVF\/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015;21(6):809\u201325.","journal-title":"Hum Reprod Update"},{"issue":"7","key":"1506_CR33","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/j.fertnstert.2010.05.056","volume":"94","author":"D de Ziegler","year":"2010","unstructured":"de Ziegler D, et al. Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril. 2010;94(7):2796\u20139.","journal-title":"Fertil Steril"},{"issue":"5","key":"1506_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.rbmo.2020.07.022","volume":"41","author":"F Barra","year":"2020","unstructured":"Barra F, et al. Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle. Reprod Biomed Online. 2020;41(5):859\u201368.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"1506_CR35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12884-021-03736-2","volume":"21","author":"E Khalifa","year":"2021","unstructured":"Khalifa E, et al. Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial. BMC Pregnancy Childbirth. 2021;21(1):264.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"1506_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000529400","volume":"88","author":"X Li","year":"2023","unstructured":"Li X, et al. Pretreatment of dienogest for women with endometriosis in in vitro fertilization: a systematic review and meta-analysis. Gynecol Obstet Invest. 2023;88(3):135\u201342.","journal-title":"Gynecol Obstet Invest"},{"issue":"12","key":"1506_CR37","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1007\/s43032-024-01701-w","volume":"31","author":"JK Meneghetti","year":"2024","unstructured":"Meneghetti JK, et al. Effect of dietary interventions on endometriosis: a systematic review and meta-analysis of randomized controlled trials. Reprod Sci. 2024;31(12):3613\u201323.","journal-title":"Reprod Sci"},{"issue":"14","key":"1506_CR38","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1001\/jama.1986.03370140102032","volume":"255","author":"DW Cramer","year":"1986","unstructured":"Cramer DW, et al. The relation of endometriosis to menstrual characteristics, smoking, and exercise. JAMA. 1986;255(14):1904\u20138.","journal-title":"JAMA"},{"issue":"1","key":"1506_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/EDE.0b013e3181c15d40","volume":"21","author":"AF Vitonis","year":"2010","unstructured":"Vitonis AF, et al. Adult physical activity and endometriosis risk. Epidemiology. 2010;21(1):16\u201323.","journal-title":"Epidemiology"},{"issue":"20","key":"1506_CR40","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1001\/jama.2024.18207","volume":"332","author":"DB Seifer","year":"2024","unstructured":"Seifer DB, Feinberg EC, Hsu AL. Ovarian aging and fertility. JAMA. 2024;332(20):1750\u20131.","journal-title":"JAMA"},{"issue":"3","key":"1506_CR41","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jmig.2012.01.010","volume":"19","author":"T Tulandi","year":"2012","unstructured":"Tulandi T, Marzal A. Redefining reproductive surgery. J Minim Invasive Gynecol. 2012;19(3):296\u2013306.","journal-title":"J Minim Invasive Gynecol"},{"key":"1506_CR42","doi-asserted-by":"publisher","first-page":"4698314","DOI":"10.1155\/2016\/4698314","volume":"2016","author":"N Pereira","year":"2016","unstructured":"Pereira N, et al. Antibiotic prophylaxis for gynecologic procedures prior to and during the utilization of assisted reproductive technologies: a systematic review. J Pathog. 2016;2016:4698314.","journal-title":"J Pathog"},{"issue":"5","key":"1506_CR43","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1472-6483(10)61192-3","volume":"12","author":"A Demirol","year":"2006","unstructured":"Demirol A, et al. Effect of endometrioma cystectomy on IVF outcome: a prospective randomized study. Reprod Biomed Online. 2006;12(5):639\u201343.","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"1506_CR44","doi-asserted-by":"publisher","first-page":"e0202399","DOI":"10.1371\/journal.pone.0202399","volume":"13","author":"M Bourdon","year":"2018","unstructured":"Bourdon M, et al. Endometriosis and ART: a prior history of surgery for OMA is associated with a poor ovarian response to hyperstimulation. PLoS ONE. 2018;13(8):e0202399.","journal-title":"PLoS ONE"},{"issue":"4","key":"1506_CR45","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/humrep\/dev029","volume":"30","author":"A Roustan","year":"2015","unstructured":"Roustan A, et al. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome. Hum Reprod. 2015;30(4):840\u20137.","journal-title":"Hum Reprod"},{"key":"1506_CR46","doi-asserted-by":"publisher","unstructured":"Riemma G, et al. Surgery prior to IVF\/ICSI versus up-front IVF\/ICSI for the treatment of infertility associated with ovarian and deep infiltrating endometriosis: a systematic review and meta-analysis. Reprod BioMed Online; 2025.\u00a0https:\/\/doi.org\/10.1016\/j.rbmo.2025.105178.","DOI":"10.1016\/j.rbmo.2025.105178"},{"issue":"8","key":"1506_CR47","doi-asserted-by":"publisher","first-page":"e0271173","DOI":"10.1371\/journal.pone.0271173","volume":"17","author":"J Ottolina","year":"2022","unstructured":"Ottolina J, et al. Surgery versus IVF for the treatment of infertility associated to ovarian and deep endometriosis (SVIDOE: surgery versus IVF for deep and ovarian endometriosis). Clinical protocol for a multicenter randomized controlled trial. PLoS ONE. 2022;17(8):e0271173.","journal-title":"PLoS ONE"},{"issue":"9","key":"1506_CR48","doi-asserted-by":"publisher","first-page":"e0239846","DOI":"10.1371\/journal.pone.0239846","volume":"15","author":"L Miquel","year":"2020","unstructured":"Miquel L, et al. Endometrioma ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis. PLoS ONE. 2020;15(9):e0239846.","journal-title":"PLoS ONE"},{"issue":"10","key":"1506_CR49","doi-asserted-by":"publisher","first-page":"102835","DOI":"10.1016\/j.jogoh.2024.102835","volume":"53","author":"A Rabattu","year":"2024","unstructured":"Rabattu A, et al. Ethanol sclerotherapy of endometriomas prior to IVF\/ICSI improves progressive pregnancy and live birth rate. J Gynecol Obstet Hum Reprod. 2024;53(10):102835.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"1506_CR50","doi-asserted-by":"publisher","unstructured":"Henry L, et al. Oocyte cryopreservation in patients with endometriosis: current knowledge and number needed to treat. J Clin Med 2022;11(15) https:\/\/doi.org\/10.3390\/jcm11154559","DOI":"10.3390\/jcm11154559"},{"issue":"4","key":"1506_CR51","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.fertnstert.2019.11.017","volume":"113","author":"A Cobo","year":"2020","unstructured":"Cobo A, et al. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study. Fertil Steril. 2020;113(4):836\u201344.","journal-title":"Fertil Steril"},{"issue":"2","key":"1506_CR52","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijgo.2007.08.021","volume":"100","author":"C Ma","year":"2008","unstructured":"Ma C, et al. Ovarian suppression treatment prior to in-vitro fertilization and embryo transfer in Chinese women with stage III or IV endometriosis. Int J Gynaecol Obstet. 2008;100(2):167\u201370.","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"1506_CR53","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.rbmo.2020.06.020","volume":"41","author":"E Rodr\u00edguez-T\u00e1rrega","year":"2020","unstructured":"Rodr\u00edguez-T\u00e1rrega E, et al. Effect of GnRH agonist before IVF on outcomes in infertile endometriosis patients: a randomized controlled trial. Reprod Biomed Online. 2020;41(4):653\u201362.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"1506_CR54","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.fertnstert.2019.12.018","volume":"113","author":"A Kaponis","year":"2020","unstructured":"Kaponis A, et al. Ultralong administration of gonadotropin-releasing hormone agonists before in vitro fertilization improves fertilization rate but not clinical pregnancy rate in women with mild endometriosis: a prospective, randomized, controlled trial. Fertil Steril. 2020;113(4):828\u201335.","journal-title":"Fertil Steril"},{"key":"1506_CR55","doi-asserted-by":"publisher","unstructured":"Georgiou EX, et al. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis. Cochrane Database Syst Rev. 2019;2019(11):CD013240. https:\/\/doi.org\/10.1002\/14651858.CD013240.pub2.","DOI":"10.1002\/14651858.CD013240.pub2"},{"issue":"3","key":"1506_CR56","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/AOG.0000000000000964","volume":"126","author":"AD DiVasta","year":"2015","unstructured":"DiVasta AD, et al. Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis: a randomized controlled trial. Obstet Gynecol. 2015;126(3):617\u201327.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"1506_CR57","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/1933719112438061","volume":"19","author":"K Chwalisz","year":"2012","unstructured":"Chwalisz K, Surrey E, Stanczyk FZ. The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis. Reprod Sci. 2012;19(6):563\u201371.","journal-title":"Reprod Sci"},{"issue":"1","key":"1506_CR58","first-page":"98","volume":"1","author":"S Piedimonte","year":"2020","unstructured":"Piedimonte S, et al. Pretreatment with a gonadotropin-releasing hormone agonist and an aromatase inhibitor may improve outcomes in in vitro fertilization cycles of women with stage I-II endometriosis. F S Sci. 2020;1(1):98\u2013103.","journal-title":"F S Sci"},{"issue":"4","key":"1506_CR59","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.rbmo.2018.12.028","volume":"38","author":"A Cantor","year":"2019","unstructured":"Cantor A, et al. A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF. Reprod Biomed Online. 2019;38(4):520\u20137.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"1506_CR60","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1056\/NEJMoa1700089","volume":"377","author":"HS Taylor","year":"2017","unstructured":"Taylor HS, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377(1):28\u201340.","journal-title":"N Engl J Med"},{"issue":"10343","key":"1506_CR61","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/S0140-6736(22)00622-5","volume":"399","author":"LC Giudice","year":"2022","unstructured":"Giudice LC, et al. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet. 2022;399(10343):2267\u201379.","journal-title":"Lancet"},{"issue":"4","key":"1506_CR62","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/GRF.0000000000000664","volume":"64","author":"AM Kotlyar","year":"2021","unstructured":"Kotlyar AM, Pal L, Taylor HS. Eliminating hormones with orally active gonadotropin-releasing hormone antagonists. Clin Obstet Gynecol. 2021;64(4):837\u201349.","journal-title":"Clin Obstet Gynecol"},{"issue":"6","key":"1506_CR63","doi-asserted-by":"publisher","first-page":"e052043","DOI":"10.1136\/bmjopen-2021-052043","volume":"12","author":"H Taylor","year":"2022","unstructured":"Taylor H, et al. Pre-IVF treatment with a GnRH antagonist in women with endometriosis (PREGNANT): study protocol for a prospective, double-blind, placebo-controlled trial. BMJ Open. 2022;12(6):e052043.","journal-title":"BMJ Open"},{"issue":"3","key":"1506_CR64","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.fertnstert.2021.11.013","volume":"117","author":"T Harada","year":"2022","unstructured":"Harada T, et al. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study. Fertil Steril. 2022;117(3):583\u201392.","journal-title":"Fertil Steril"},{"issue":"5","key":"1506_CR65","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk CB, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23(5):560\u201379.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1506_CR66","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.rbmo.2014.05.007","volume":"29","author":"D Grow","year":"2014","unstructured":"Grow D, et al. GnRH agonist and GnRH antagonist protocols: comparison of outcomes among good-prognosis patients using national surveillance data. Reprod Biomed Online. 2014;29(3):299\u2013304.","journal-title":"Reprod Biomed Online"},{"key":"1506_CR67","doi-asserted-by":"publisher","unstructured":"USE: Ovarian Stimulation TEGGO, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, et al. ESHRE guideline: ovarian stimulation for IVF\/ICSI\u2020. Hum Reprod Open. 2020;2020(2):hoaa009. https:\/\/doi.org\/10.1093\/hropen\/hoaa009.","DOI":"10.1093\/hropen\/hoaa009"},{"issue":"12","key":"1506_CR68","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1093\/humrep\/del207","volume":"21","author":"B Asimakopoulos","year":"2006","unstructured":"Asimakopoulos B, et al. Cytokine and hormonal profile in blood serum and follicular fluids during ovarian stimulation with the multidose antagonist or the long agonist protocol. Hum Reprod. 2006;21(12):3091\u20135.","journal-title":"Hum Reprod"},{"issue":"4","key":"1506_CR69","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.fertnstert.2006.12.046","volume":"88","author":"R Pabuccu","year":"2007","unstructured":"Pabuccu R, Onalan G, Kaya C. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization\/intracytoplasmic sperm injection cycles. Fertil Steril. 2007;88(4):832\u20139.","journal-title":"Fertil Steril"},{"issue":"9","key":"1506_CR70","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jogoh.2017.09.007","volume":"46","author":"K Kolanska","year":"2017","unstructured":"Kolanska K, et al. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist. J Gynecol Obstet Hum Reprod. 2017;46(9):681\u20136.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"10","key":"1506_CR71","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1080\/09513590.2018.1460346","volume":"34","author":"P Drakopoulos","year":"2018","unstructured":"Drakopoulos P, et al. Does the type of GnRH analogue used, affect live birth rates in women with endometriosis undergoing IVF\/ICSI treatment, according to the rAFS stage? Gynecol Endocrinol. 2018;34(10):884\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"1506_CR72","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/jog.15570","volume":"49","author":"Q Chen","year":"2023","unstructured":"Chen Q, et al. Controlled ovarian stimulation for endometriosis patients with ultra-long GnRH-agonist or GnRH-antagonist protocols: a retrospective study by propensity score matching. J Obstet Gynaecol Res. 2023;49(5):1366\u201374.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"1506_CR73","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13048-020-00620-z","volume":"13","author":"E Mathieu d'Argent","year":"2020","unstructured":"Mathieu d\u2019Argent E, et al. Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols. J Ovarian Res. 2020;13(1):18.","journal-title":"J Ovarian Res"},{"issue":"6","key":"1506_CR74","doi-asserted-by":"publisher","first-page":"102950","DOI":"10.1016\/j.jogoh.2025.102950","volume":"54","author":"M Calero","year":"2025","unstructured":"Calero M, et al. Fertility preservation in women with endometriosis: a retrospective non-inferiority study comparing Dienogest in the PPOS protocol to antagonist and agonist protocols. J Gynecol Obstet Hum Reprod. 2025;54(6):102950.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"2","key":"1506_CR75","doi-asserted-by":"publisher","first-page":"103639","DOI":"10.1016\/j.rbmo.2023.103639","volume":"48","author":"B Ata","year":"2024","unstructured":"Ata B, Kalafat E. Progestin-primed ovarian stimulation: for whom, when and how? Reprod Biomed Online. 2024;48(2):103639.","journal-title":"Reprod Biomed Online"},{"key":"1506_CR76","doi-asserted-by":"publisher","first-page":"1507252","DOI":"10.3389\/fendo.2025.1507252","volume":"16","author":"Y Han","year":"2025","unstructured":"Han Y, et al. Pregnancy outcomes in freeze-all versus fresh embryo transfer cycles of women with adenomyosis and endometriosis: a systemic review and meta-analysis. Front Endocrinol (Lausanne). 2025;16:1507252.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"1506_CR77","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1093\/humrep\/dex285","volume":"32","author":"S Mackens","year":"2017","unstructured":"Mackens S, et al. Frozen embryo transfer: a review on the optimal endometrial preparation and timing. Hum Reprod. 2017;32(11):2234\u201342.","journal-title":"Hum Reprod"},{"issue":"2","key":"1506_CR78","doi-asserted-by":"publisher","first-page":"126.e1","DOI":"10.1016\/j.ajog.2019.03.010","volume":"221","author":"E Ginstr\u00f6m Ernstad","year":"2019","unstructured":"Ginstr\u00f6m Ernstad E, et al. Neonatal and maternal outcome after frozen embryo transfer: increased risks in programmed cycles. Am J Obstet Gynecol. 2019;221(2):126.e1-126.e18.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1506_CR79","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.fertnstert.2020.10.039","volume":"115","author":"LL Asserh\u00f8j","year":"2021","unstructured":"Asserh\u00f8j LL, et al. Adverse obstetric and perinatal outcomes in 1,136 singleton pregnancies conceived after programmed frozen embryo transfer (FET) compared with natural cycle FET. Fertil Steril. 2021;115(4):947\u201356.","journal-title":"Fertil Steril"},{"issue":"6","key":"1506_CR80","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/humrep\/dex066","volume":"32","author":"T Tatsumi","year":"2017","unstructured":"Tatsumi T, et al. Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles. Hum Reprod. 2017;32(6):1244\u20138.","journal-title":"Hum Reprod"},{"issue":"6","key":"1506_CR81","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.rbmo.2022.06.026","volume":"45","author":"L Lou","year":"2022","unstructured":"Lou L, et al. Comparison of different endometrial preparation protocols on frozen embryo transfer pregnancy outcome in patients with normal ovulation. Reprod Biomed Online. 2022;45(6):1182\u20137.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"1506_CR82","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.fertnstert.2022.06.013","volume":"118","author":"P Godiwala","year":"2022","unstructured":"Godiwala P, et al. Pregnancy outcomes after frozen-thawed embryo transfer using letrozole ovulation induction, natural, or programmed cycles. Fertil Steril. 2022;118(4):690\u20138.","journal-title":"Fertil Steril"},{"issue":"1","key":"1506_CR83","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12958-023-01132-3","volume":"21","author":"J Yang","year":"2023","unstructured":"Yang J, et al. Retrospective analysis of the endometrial preparation protocols for frozen-thawed embryo transfer cycles in women with endometriosis. Reprod Biol Endocrinol. 2023;21(1):83.","journal-title":"Reprod Biol Endocrinol"},{"issue":"12","key":"1506_CR84","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s10815-015-0592-1","volume":"32","author":"FB Cordeiro","year":"2015","unstructured":"Cordeiro FB, et al. Lipidomics analysis of follicular fluid by ESI-MS reveals potential biomarkers for ovarian endometriosis. J Assist Reprod Genet. 2015;32(12):1817\u201325.","journal-title":"J Assist Reprod Genet"},{"issue":"7","key":"1506_CR85","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/humrep\/dez053","volume":"34","author":"H Ferrero","year":"2019","unstructured":"Ferrero H, et al. Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals a differential transcriptomic profile associated with lower quality. Hum Reprod. 2019;34(7):1302\u201312.","journal-title":"Hum Reprod"},{"issue":"1\u20132","key":"1506_CR86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mce.2008.07.020","volume":"301","author":"T Smuc","year":"2009","unstructured":"Smuc T, et al. Disturbed estrogen and progesterone action in ovarian endometriosis. Mol Cell Endocrinol. 2009;301(1\u20132):59\u201364.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"1506_CR87","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1210\/jc.2008-2218","volume":"94","author":"B Delvoux","year":"2009","unstructured":"Delvoux B, et al. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab. 2009;94(3):876\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1506_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1055\/s-2004-823026","volume":"22","author":"SE Bulun","year":"2004","unstructured":"Bulun SE, et al. Aromatase and endometriosis. Semin Reprod Med. 2004;22(1):45\u201350.","journal-title":"Semin Reprod Med"},{"issue":"1 Suppl Proceed","key":"1506_CR89","first-page":"S40","volume":"8","author":"HR Behrman","year":"2001","unstructured":"Behrman HR, et al. Oxidative stress and the ovary. J Soc Gynecol Investig. 2001;8(1 Suppl Proceedings):S40\u20132.","journal-title":"J Soc Gynecol Investig"},{"issue":"6","key":"1506_CR90","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0015-0282(02)03103-5","volume":"77","author":"T Seino","year":"2002","unstructured":"Seino T, et al. Eight-hydroxy-2\u2019-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program. Fertil Steril. 2002;77(6):1184\u201390.","journal-title":"Fertil Steril"},{"key":"1506_CR91","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.reprotox.2013.08.005","volume":"42","author":"AK Singh","year":"2013","unstructured":"Singh AK, et al. Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF. Reprod Toxicol. 2013;42:116\u201324.","journal-title":"Reprod Toxicol"},{"issue":"2","key":"1506_CR92","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/0974-1208.101020","volume":"5","author":"S Rajani","year":"2012","unstructured":"Rajani S, et al. Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindle imaging and reactive oxygen species levels in follicular fluid and its relationship with IVF-ET outcome. J Hum Reprod Sci. 2012;5(2):187\u201393.","journal-title":"J Hum Reprod Sci"},{"issue":"4","key":"1506_CR93","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0015-0282(16)57506-2","volume":"63","author":"IP Ryan","year":"1995","unstructured":"Ryan IP, et al. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril. 1995;63(4):929\u201332.","journal-title":"Fertil Steril"},{"key":"1506_CR94","doi-asserted-by":"publisher","unstructured":"Hogg C. et al. Macrophages inhibit and enhance endometriosis depending on their origin. Proc Natl Acad Sci USA. 2021;118(6):e2013776118. https:\/\/doi.org\/10.1073\/pnas.2013776118.","DOI":"10.1073\/pnas.2013776118"},{"issue":"1","key":"1506_CR95","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/oxfordjournals.humrep.a019023","volume":"11","author":"J McLaren","year":"1996","unstructured":"McLaren J, et al. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod. 1996;11(1):220\u20133.","journal-title":"Hum Reprod"},{"issue":"6","key":"1506_CR96","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/S0015-0282(99)00442-2","volume":"72","author":"G Barroso","year":"1999","unstructured":"Barroso G, et al. Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients. Fertil Steril. 1999;72(6):1024\u20136.","journal-title":"Fertil Steril"},{"issue":"9","key":"1506_CR97","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1093\/humrep\/12.9.2046","volume":"12","author":"J Balasch","year":"1997","unstructured":"Balasch J, et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Hum Reprod. 1997;12(9):2046\u201350.","journal-title":"Hum Reprod"},{"issue":"4","key":"1506_CR98","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000484895","volume":"83","author":"G \u00d6nalan","year":"2018","unstructured":"\u00d6nalan G, Tohma YA, Zeynelo\u011flu HB. Effect of etanercept on the success of assisted reproductive technology in patients with endometrioma. Gynecol Obstet Invest. 2018;83(4):358\u201364.","journal-title":"Gynecol Obstet Invest"},{"key":"1506_CR99","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bpobgyn.2019.06.006","volume":"60","author":"A Kotlyar","year":"2019","unstructured":"Kotlyar A, Taylor HS, D\u2019Hooghe TM. Use of immunomodulators to treat endometriosis. Best Pract Res Clin Obstet Gynaecol. 2019;60:56\u201365.","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01506-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01506-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01506-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T08:02:01Z","timestamp":1767600121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12958-025-01506-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1506"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01506-9","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.\u00a0","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}